North America CRISPR Gene Detection and Diagnostic Market to 2032

Overview

The North America CRISPR Gene Detection and Diagnostic Market is expected to reach a 2,865.34 USD Million by 2032 and is projected to grow at a CAGR of 28.95% from 2025 to 2032.

Revenue, 2024 (USD Million)

686.10

Forecast, 2032 (USD Million)

2,865.34

CAGR, 2024 - 2032

28.95%

Report Coverage

North America

North America CRISPR Gene Detection and Diagnostic Market 2018-2032 USD Million

North America CRISPR Gene Detection and Diagnostic Market, Key Findings (2025-2032)

Market Growth and Projections:

Market Size (2024): 686.10 USD Million
Projected Market Size (2032): 2,865.34 USD Million
CAGR (2025-2032): 28.95%

Key Findings of North America CRISPR Gene Detection and Diagnostic Market

The North America CRISPR Gene Detection and Diagnostic Market was valued at 686.10 USD Million in 2024.
The North America CRISPR Gene Detection and Diagnostic Market is likely to grow at a CAGR of 28.95% during the forecast period of 2024 to 2032.
In 2024, the Largest segment Class-2 Single CrRNA-Binding Protein in Class Segment accounted for the largest share of the market with a revenue of 625.68 USD Million
The fastest growing segment CRRNA in Workflow Segment grew Fastest with a CAGR of 34.06% during the forecast period from 2024 to 2032.

North America CRISPR Gene Detection and Diagnostic Market Scope

North America CRISPR Gene Detection and Diagnostic Market Segmentation & Scope

End User

Others
Hospitals
Diagnostic Centers
Academic and Research Institutes
Biotechnology Companies

Distribution Channel

Retail Sales
Direct Tender

Application

Others
Drug Discovery
Genome Engineering
Agricultural Applications
Biomedical Diagnostics

Workflow

Sensing
Sample Preparation
Pre-Amplification
Cas Enzyme
CRRNA

Products and Services

Services
Products

Class

Class-1 Multiple Effector Proteins
Class-2 Single CrRNA-Binding Protein

North America CRISPR Gene Detection and Diagnostic Market Data Coverage Insights

Study Period	2024-2032
Base Year	2021
Unit	Revenue in USD Million
Market Value in 2024	686.10 USD Million
Market Value in 2032	2,865.34 USD Million
CAGR (2025-2032)	28.95%
Historic Data	2016-2023
Market Segments Covered	End User,Distribution Channel,Application,Workflow,Products and Services,Class

Regional Insights:

Leading Market (2024-2032): North America, leading in terms of revenue 686.10 USD Million in 2024
- Key Country: U.S., leading in terms of revenue with value of 628.73 USD Million in 2024.

Segments and Scope

North America CRISPR Gene Detection and Diagnostic Market to 2032, By End User
- Biotechnology Companies is the largest segment in North America CRISPR Gene Detection and Diagnostic Market to 2032 with a revenue of 305.09 USD Million in the year 2024.
- Biotechnology Companies is the Fastest growing segment in North America CRISPR Gene Detection and Diagnostic Market to 2032 with a Growth rate of 33.50 % in forecast period 2025-2032.
North America CRISPR Gene Detection and Diagnostic Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in North America CRISPR Gene Detection and Diagnostic Market to 2032 with a revenue of 292.05 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in North America CRISPR Gene Detection and Diagnostic Market to 2032 with a Growth rate of 32.51 % in forecast period 2025-2032.
North America CRISPR Gene Detection and Diagnostic Market to 2032, By Application
- Biomedical Diagnostics is the largest segment in North America CRISPR Gene Detection and Diagnostic Market to 2032 with a revenue of 396.17 USD Million in the year 2024.
- Biomedical Diagnostics is the Fastest growing segment in North America CRISPR Gene Detection and Diagnostic Market to 2032 with a Growth rate of 32.39 % in forecast period 2025-2032.
North America CRISPR Gene Detection and Diagnostic Market to 2032, By Workflow
- CRRNA is the largest segment in North America CRISPR Gene Detection and Diagnostic Market to 2032 with a revenue of 225.17 USD Million in the year 2024.
- CRRNA is the Fastest growing segment in North America CRISPR Gene Detection and Diagnostic Market to 2032 with a Growth rate of 34.06 % in forecast period 2025-2032.
North America CRISPR Gene Detection and Diagnostic Market to 2032, By Products and Services
- Products is the largest segment in North America CRISPR Gene Detection and Diagnostic Market to 2032 with a revenue of 454.95 USD Million in the year 2024.
- Products is the Fastest growing segment in North America CRISPR Gene Detection and Diagnostic Market to 2032 with a Growth rate of 30.12 % in forecast period 2025-2032.
North America CRISPR Gene Detection and Diagnostic Market to 2032, By Class
- Class-2 Single CrRNA-Binding Protein is the largest segment in North America CRISPR Gene Detection and Diagnostic Market to 2032 with a revenue of 625.68 USD Million in the year 2024.
- Class-2 Single CrRNA-Binding Protein is the Fastest growing segment in North America CRISPR Gene Detection and Diagnostic Market to 2032 with a Growth rate of 29.92 % in forecast period 2025-2032.

North America CRISPR Gene Detection and Diagnostic Market Company Share Analysis

Company Name
Merck KGaA
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
10x Genomics
GenScript

North America CRISPR Gene Detection and Diagnostic Market Geographical Sales Distribution, 2018-2032 USD Million

North America CRISPR Gene Detection and Diagnostic Market Company Profiling

Industry Related Reports

South America Cell And Gene Therapy Thawing Equipment Market

Middle East & Africa Cell And Gene Therapy Thawing Equipment Market

North America Cell And Gene Therapy Thawing Equipment Market

Europe Cell And Gene Therapy Thawing Equipment Market

Asia-Pacific Cell And Gene Therapy Thawing Equipment Market

Argentina Cell And Gene Therapy Thawing Equipment Market

Australia Cell And Gene Therapy Thawing Equipment Market

Belgium Cell And Gene Therapy Thawing Equipment Market

Brazil Cell And Gene Therapy Thawing Equipment Market

Canada Cell And Gene Therapy Thawing Equipment Market

Frequently Asked Questions

What are the primary segments covered in the North America CRISPR Gene Detection and Diagnostic Market?

The North America CRISPR Gene Detection and Diagnostic Market is segmented based on Segmentation End User,Distribution Channel,Application,Workflow,Products and Services,Class.

What is the current market size of the North America CRISPR Gene Detection and Diagnostic Market?

North America CRISPR Gene Detection and Diagnostic Market was valued at USD 686.10(Revenue in USD Million) in 2021.

What is the expected growth rate of the North America CRISPR Gene Detection and Diagnostic Market?

North America CRISPR Gene Detection and Diagnostic Market is projected to grow at a CAGR of 28.95% during the forecast period of 2024 to 2032.

Which is the dominating segment in the North America CRISPR Gene Detection and Diagnostic Market?

The Class-2 Single CrRNA-Binding Protein segment is expected to dominate the North America CRISPR Gene Detection and Diagnostic Market, holding a largest market share of 625.68 USD Million in 2024